Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 17, 2021 - Issue
Submit an article Journal homepage
151
Views
3
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study

Masaomi Iyo1 Department of Psychiatry, Graduate School of Medicine, Chiba University, Chiba, JapanORCID Iconhttps://orcid.org/0000-0002-5384-857XView further author information
ORCID Icon,
Jun Ishigooka2 Institute of CNS Pharmacology, Tokyo, JapanView further author information
,
Masatoshi Nakamura3 Department of Data Science, Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-6100-5417View further author information
ORCID Icon,
Reiko Sakaguchi4 Department of Clinical Research, Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, JapanView further author information
,
Keisuke Okamoto5 Department of Clinical Operation, Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, JapanView further author information
,
Yongcai Mao6 Division of Data Science, Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USAView further author information
,
Joyce Tsai7 Division of Clinical Research, Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USAView further author information
,
Alison Fitzgerald8 Division of Clinical Operations, Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USAView further author information
,
Kentaro Takai9 Medical Affairs, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6105-4502View further author information
ORCID Icon &
Teruhiko Higuchi10 Japan Depression Center, Tokyo, Japan;11 National Center of Neurology and Psychiatry, Tokyo, JapanView further author information
 show all
Pages 2683-2695 | Published online: 16 Aug 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.